Ep. 53 - Bob Nelsen on AI, China and the IRA

This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com (https://biocenturyyoutube.com/) to access and watch all prior episodes.

In a wide-ranging conversation with BioCentury, Bob Nelsen, co-founder and managing director of Arch Venture Partners, said he is excited by the potential for AI to “create a language of biology,” is cautious about investing in China given increasing geopolitical tensions, and is convinced that the U.S. healthcare system could do a far better job of delivering on the promise of rapidly progressing science.
Nelsen, who has helped finance and create more than 150 companies, including 47 that have reached valuations exceeding $1 billion, discussed his conviction that focusing on creating transformational medicines, rather than looking for short-term gains, is a key to success in the life sciences.

View full story: https://www.biocentury.com/article/65...

#biotech #pharma #biopharma #TheBioCenturyShow 

00:00 - Intro
02:00 - The Promise of AI 
08:37 - The Inflation Reduction Act
15:50 - China
26:04 - Building Companies Around Big challenges